Dados B3 › SNSY5 × SUZB3
SNSY5 × SUZB3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | SNSY5 | SUZB3 | year |
|---|---|---|---|
| ROE | — | 35.2% | no year where both have it |
| ROIC | — | 6.2% | no year where both have it |
| ROA | -50.7% | 8.0% | 2025 |
| Gross margin | 19.5% | 32.4% | 2025 |
| EBIT margin | -2.5% | 21.2% | 2025 |
| Net margin | -29.1% | 26.8% | 2025 |
| Net debt/EBITDA | 0.59x | 3.19x | 2024 |
| Current ratio | 0.65x | 3.19x | 2025 |
| Revenue growth (1y) | 3.3% | 5.7% | 2025 |
| Revenue growth (5y CAGR) | 13.8% | 10.5% | 2025 |
| Piotroski F-Score | 4/9 | 8/9 | 2025 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | SNSY5 | SUZB3 | year |
|---|---|---|---|
| P/E | -0.07x | 4.71x | 2025 |
| P/B | — | 1.44x | 2025 |
| EV/EBITDA | — | 6.05x | 2025 |
| FCF yield | -93.3% | 21.4% | 2025 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 11:32 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 11:32 UTC. If this does not match /saude, you are reading a cached copy.